Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate L. Dishart

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biomedicine & Biotechnology|May 2, 2003
Gene Therapy for Cardiovascular DiseaseKate L. Dishart, Lorraine M. Work, Laura Denby, et al.
Cancer Letters|November 11, 2003
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectorsStuart A Nicklin, Kate L Dishart, Hildegard Buening, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Development of efficient viral vectors selective for vascular smooth muscle cellsLorraine M Work, Stuart A Nicklin, Nick J R Brain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loopAngelika B Kritz, Campbell G Nicol, Kate L Dishart, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2003
Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapyKate L Dishart, Laura Denby, Sarah J George, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biomedicine & Biotechnology|May 2, 2003
Gene Therapy for Cardiovascular DiseaseKate L. Dishart, Lorraine M. Work, Laura Denby, et al.
Cancer Letters|November 11, 2003
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectorsStuart A Nicklin, Kate L Dishart, Hildegard Buening, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Development of efficient viral vectors selective for vascular smooth muscle cellsLorraine M Work, Stuart A Nicklin, Nick J R Brain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loopAngelika B Kritz, Campbell G Nicol, Kate L Dishart, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2003
Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapyKate L Dishart, Laura Denby, Sarah J George, et al.
Pageof 1